Serum obtained from mice 3 to 5 weeks after the third i.p. dose of dengue type 2 virus (DV) protected recipient mice against intracerebral challenge with DV, whereas the serum obtained after I and 2 weeks provided minimum protection. Adoptive intravenous transfer of immune spleen cells obtained from mice I to 5 weeks after immunization did not protect recipient mice against even a small dose (IO LDs0 ) of DV. Depletion of T-cells by treatment of mice with anti-thymocyte serum did not potentiate DV infection. Development of a cell-mediated immune response (CMI) against DV was noted only at two periods by the leucocyte migration inhibition test (LMI), with borderline values of 20 and 21%. Dengue virus did not cause illness or death in mice when given by i.p. or i.v. routes and this was not affected by pre-treatment of mice with silica to damage local macrophages. It is concluded that humoral antibody plays a critical role in recovery from primary dengue virus infection of mice whereas CMI and macrophages appear to have no protective role.
INTRODUCTION
Dengue virus infection in humans may be associated with haemorrhagic manifestations (Rao & Anderson, I964; Halstead, 1966; Chaturvedi et al. ~97oa, b) . There is a possibility that immunopathological processes determine whether infection with dengue virus results in a benign or a haemorrhagic fever (Halstead, I966; Hammon, 1966) , although our findings on three epidemics of dengue do not support this view (Kapoor et al. 1978) .
Immune mechanisms play an important role in recovery from virus infections. Humoral antibody and cell-mediated immunity (CMI) may both be active, but in a number of virus infections the role of CMI is considered to be more important (Allison, 1972) . A contributory factor in the development of resistance against herpes simplex, yellow fever and Coxsackie B3 virus infection is the macrophage (Hirsch et al. I97o; Zisman et al. I97I ; RagerZisman & Allison, 1973) . Halstead et al. (1973) have reported peripheral blood lymphocyte stimulation in monkeys infected with dengue virus. They have also shown that replication of the virus occurs to a greater extent in cells previously exposed to DV than in normal cells (Marchette et aL 1976) . In our previous study we noted that antibody plays a critical role in recovery from acute DV infection of immunosuppressed mice (Chaturvedi et al. 1977) . In the present study we investigated the role of CMI, macrophages and antibody in the protection of mice against DV infection.
Titration ofD V. Localization of virus in different organs of adult mice, namely brain, heart, liver and spleen, were determined at different days after i.c. inoculation of DV. At autopsy, brain, liver, spleen and heart were removed. The organs were cut into thin slices and repeatedly washed with ice-cold Hanks' balanced salt solution (HBSS) until the wash solution was free of blood. A IO% (w/v) organ suspension was prepared in chilled Eagle's minimum essential medium (MEM) containing antibiotics and lO% heat inactivated new-born calf serum. It was clarified by centrifugation in the cold and serial Io-fold dilutions prepared in MEM were inoculated i.c. into groups of adult mice using doses of 0"03 ml. Mice were observed for 21 days and the LDs0 was calculated by the method of Reed & Muench (I938) .
Antibody titres. Individual mouse sera were assayed for haemagglutination inhibiting (HI) antibody by the technique of Clarke & Casals (I958) using 8 HA units of antigen and i-day-old chick red blood cells. The freeze-dried antigen of dengue type 2 virus (strain 23o85) was obtained from the Virus Research Centre, Poona.
Donor cells for adoptive immunization.
Adult mice were given o'5 ml of a 2o % suspension of DV infected mouse brain by intraperitoneal (i.p.) inoculation. Three such doses were given at weekly intervals. At I, 2, 3, 4 and 5 weeks after the third dose, groups of mice were sacrificed. The spleen cells were teased out in MEM and the cell clumps were removed by aspiration. The cells were washed once and resuspended in MEM and counted in a haemocytometer. In different preparations the viable nucleated cells ranged from 90 to 94 % as assessed by the trypan blue dye exclusion test.
Sensitized spleen cells were injected intravenously into normal mice at doses of I to 4 x lO 8 cells. After 24 h they were challenged with varying doses of DV intracerebrally. Control groups received spleen cells from non-immune mice.
Serum for adoptive immunization. From the group of mice used as donors of sensitized spleen cells for adoptive immunization, blood was collected directly from the heart at I, 2, 3, 4 and 5 weeks after the third dose of DV i.p. The blood was pooled from similarly treated mice and the serum was separated and stored at -2o °C until used. The serum was diluted IO, ioo, 3oo and 5oo-fold and injected in doses of o'5 ml i.p. into normal mice followed 24 h later by IO 2 LD~o of DV i.c.
Effect of adoptive cell transfer on antibody forming cells.
To investigate the presence of suppressor cells in the immunized mice the following experiment was done. Mice of group A were given o. 5 ml of IO ~ LDs0 DV i.p. Mice of group B were given the same amount of DV i.p. followed 48 h later by the adoptive transfer of IO 8 immune spleen cells i.v. In mice of group C the DV given i.p. was followed 48 h later by adoptive transfer of IO s normal mouse spleen cells i.v. Mice from each group were sacrificed in batches of 4 to 5 daily for 9 days beginning 24 h (in group A) or 72 h (in groups B and C) after infection. The spleens were collected and direct antibody forming cells against DV were counted by the technique of Jerne & Nordin (1963) as described elsewhere (Chaturvedi et al. I977; Tandon & Chaturvedi, I977) . The immune spleen cells were obtained at various periods after immunization as described above for adoptive transfer. The peak antibody forming cell response was observed after 6 or 7 days and therefore, in another set of experiments, sensitized spleen cells obtained at 3 days and I to 5 weeks after immunization were transferred into normal mice as described above and the antibody forming cells were counted 6 and 7 days after DV was given i.p.
Preparation of anti-thymocyte serum (ATS).
Antiserum against the thymocytes of Swiss mice was prepared in albino rabbits by the method of Levey & Medawar (I966) as described by Blanden 097o). Briefly, the rabbits were given two successive intravenous injections, I4 days apart, of a single cell suspension of z × Io 8 viable thymocytes. The rabbits were bled 7 days after the second injection. Serum was separated, pooled and stored in small portions at -7 ° °C after inactivation at 56 °C for 3o min. The cytotoxic titres against mouse thymocytes and spleen cells were determined in the presence of complement by the technique of Golub 097I)-The cytotoxicity was comparable to that of the anti-theta serum (prepared in mice immunized with thymocytes from young CzH/HeJ mice) obtained from Bionetics. Maryland, U.S.A. Treatment with these sera in the presence of complement killed 4I"5 °o of the spleen cells.
Depletion of T-lymphocytes.
The ATS was given in doses of o.I ml i.p. on alternate days from z days before the IO 2 LDs0 i.c. DV inoculation until the ~Ith day after inoculation (Camenga et al. I974) . The control group was similarly treated with normal rabbit serum.
Effect of cyclophosphamide. Mice were given cyclophosphamide (Endoxan-ASTA, Khandelwal Lab. Pvt. Ltd., ASTA-Werke, A-G, West Germany) in a single dose of 25o mg/kg body weight i.p. 24 h after ~o 2 LDs0 DV was given intracerebrally.
Leucocyte migration inhibition test (LMI). This test was performed by the method of David et al. 0964) with spleen cells of mice given DV in various doses by different routes
as follows. In mice of group A, o'o3 ml of Io z LDs0 of DV was inoculated i.c. and mice were sacrificed in batches of 5 at 24 h intervals from day I to ~o. Mice of group B were given o.I ml DV i.p. and group C received I ml of Io z LDs0 ofDV i.p. Mice of both these groups were sacrificed daily in batches of 4 to 5 from day I to 23 and then at 28 and 35 days. Mice of group D were given three i.p. doses of o'5 ml of 2o % DV infected mouse brain suspension at weekly intervals and the mice were sacrificed I, z, 3, 4, 5 and 6 weeks after the last dose.
There was almost no difference in the migration pattern whether live DV antigen or ultraviolet inactivated antigen was used. All the tests were set up in triplicate from each mouse. After incubation for about 24 h at 37 °C the migration pattern of the leucocytes was recorded on Whatman No. I chromatographic paper with the Camera Lucida, using a magnification of × I5. The area of migration was cut out and the paper was weighed. The °0 migration inhibition was calculated according to David et al. (1964) . An inhibition of 2o °~o or more was considered significant (Oritz-Oritz et al. I974) .
Effect of damage ofmacrophages. Failure to produce illness in mice by i.p. or i.v. inoculation of dengue virus, as observed in previous experiments, could be due to non-specific resistance by macrophages. Macrophages can be destroyed specifically by silica particles (Allison et al. 1966) . Therefore, mice of groups A and B were given 5 ° mg of 2 #m sterilized silica particles (quartz dust) i.p.; mice of groups C and D were given 3 mg silica particles i.v. Mice of groups A and C were challenged with IO 2 LDs0 of DV i.p. or i.v. 2 h later.
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RESULTS
Distribution of DV in the body after i.c. inoculation
Mice receiving DV intracerebrally remained apparently healthy for up to 4 days. On the 5th or 6th day the fur became ruffled and the back arched. Later, mice became markedly sick and from the 8th day paralysis of the hind limbs set in. All the mice died between 8 and I2 days after inoculation. The distribution of the virus in different organs after intracerebral inoculation of ro 2 LDso DV is shown in Fig. t . The virus was found in the brain from the 2nd day, reaching a peak on the 9th and Ioth day when the titres were IO 5"8 LDs0. The virus was detected from the 4th day in the liver, from the 5th day in the spleen and from the 7th day in the heart.
Effect of adoptive immunization by sensitized spleen cells
Adoptive immunization by sensitized spleen cells, obtained at different periods after immunization of mice, did not affect the outcome of DV infection (Table 0 . Transfer of normal mouse spleen cells to control mice also had no effect.
Effect of adoptive immunization by serum
Adoptive transfer of serum, obtained at I or 2 weeks after immunization, protected a smaller number of mice (Table 2) . At later periods the protection was marked even with a higher dilution of the serum.
Effect of adoptive transfer of sensitized cells on antibody forming cells
Adoptive transfer of immune spleen cells collected IO days after the immunization markedIy suppressed the antibody forming cells against DV in the spleen of recipient mice. The results summarized in Fig. 2 show that the maximum plaque forming cell (PFC) count in such mice was 285/2 × IO 6 spleen cells on the 7th day. In mice given normal spleen cells (group C) the peak count was 630 and in untreated controls it was 772 cells/2 x 1o 6 spleen cells.
Results of the second set of experiments where PFC were counted after i.v. transfer of immune spleen cells collected after 3 days, I, 2, 3, 4 and 5 weeks of immunization, are summarized in Table 3 . The suppression of PFC continued to occur by transfer of immune cells up to 3 weeks after immunizing the donor, while at later periods the suppressive activity diminished.
Leucocyte migration inhibition test
Only the mice of group B (o.I ml DV i.p.) showed an inhibition of 20 + 1.8 % on day I4 and the mice of group D (three doses of 0"5 ml of 2o% brain suspension i.p.) showed an inhibition of 2I + 2.8 % at 6 weeks. At every other period the migration inhibition was not significant with various doses of DV.
Effect of treatment with ATS and cyclophosphamide
The results summarized in Table 4 show that cyclophosphamide treatment reduced the mean survival time but treatment with ATS did not potentiate the virus infection. The 
Effect of blockade of macrophages
The results summarized in Table 5 show that selective destruction of macrophages by silica had no effect on the outcome of the infection.
HI antibodies
The HI antibody titre at I and 2 weeks after immunization was 20 to 4o while at 3, 4 and 5 weeks, the titres ranged from I6O to 32o. Sera of some of the mice given sensitized spleen ceils i.v. showed antibody at a dilution of I : 2o. HI antibodies were also noted in low titres in groups of mice given a single dose ofDV i.p. or i.v. from the ioth or Iath day respectively.
DISCUSSION
Passive transfer of specific antiserum protected recipient mice against i.c. challenge with DV. Serum collected at early periods (I to 2 weeks) after immunization provided minimum protection while serum collected at later periods (3 to 5 weeks) protected a greater number of mice with a higher dilution of serum. Poor protection by sera collected early may well be due to the lower concentration of antibody. In our experiments there was evidence of suppression of antigen-specific antibody secretion as detected by Jerne's plaque technique after transfer of sensitized spleen cells. The suppressor activity diminished at 4 to 5 weeks (see Table 3 ) which may be responsible for the higher concentration of HI antibody at this period and consequently greater protection by the serum transfer. Such suppression by transfer of sensitized cells was not due to feedback suppression of antibody formation by effector T-cells as suggested by Pang & Blanden (1976) because cells obtained 4 to 5 weeks after immunization were not able to significantly suppress the antibody forming cells in the spleen of recipient mice (see Table 3 ).
There are a number of host-arbovirus combinations in which virus replicates readily in Virus control --6/6 I I '3 o * Mice were immunized by three i.p. weekly doses of DV. Blood was collected at weekly intervals after'the third dose and 0"5 ml of the serum dilution was injected i.p. into normal mice, followed 24 h later [by lO 3 LDs0 of DV i.c.
I" D/T = Number of deaths/total number tested. In control mice, normal mouse serum was injected. * DV (I0 ~ LDs0) was injected intracerebrally and o.t ml antithymocyte serum (ATS) or normal rabbit serum (NRS) was given i.p. every other day from a days before infection to I2 days after infection. Cyclophosphamide (CY) was given in doses of 25o mg/kg ~ day after DV infection.
t D/T = Number of deaths/total number tested. 
IO/I0
* Mice were pre-treated intravenously or intraperitoneally with 2 #m sterile silica particles suspended in Hank's balanced salt solution to destroy the macrophages. DV was inoculated at to s LD~ 0 by the same route 2 h later. The control mice were given either silica or virus alone.
t D/T = Number of deaths/totaI number tested, brain but relatively poorly in peripheral tissues (Albrecht, 1968; Cole & Wisseman, 1969) . In the present study and in an earlier study (Chaturvedi et al. J974) high DV titres were noted in the brain tissue while liver, heart and spleen had low titres. Replication of DV associated with changes in enzymes and metabolites also occurs in skeletal muscles (Agrawal et al. I978) and in liver and brain tissues (unpublished data) in mice. When inoculated by the intraperitoneal route, dengue virus fails to kill adult mice even with very large doses (Nathanson & Cole, I97O). Out of four groups of mice sensitized wilh DV given in various doses by different routes, a significant LMI was noted only on two occasions, to the extent of 20 + 1.8 and 2I +__ 2.8%. This is in contrast to the higher values of 6o to 65 % LMI observed in Coxsackie B4 virus infected mice with specific antigen (Chaturvedi et al. I978) . Stimulation of peripheral blood lymphocyte in DV infected monkeys have been noted in some experiments by Halstead et al. (1973) .
Poor cell-mediated inlmunity in DV infection may be due to suppressor cell activity or to selective destruction of T-cells. This was shown to occur both in the circulation and in the thymus dependent areas of lymph nodes and spleen in dengue virus infection (Bhamarapravati et al. 
